We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Sigma-Aldrich Receives Merck Award

By Labmedica staff writers
Posted on 21 Mar 2007
Sigma-Aldrich, (St Louis, MO, USA), a leading US$1.8 billion life science and high technology company, has been named a recipient of Merck & Co., Inc.'s (Whitehouse Station, NJ, USA) 2006 Sector Operational Award. More...
Sigma-Aldrich was chosen for its outstanding sourcing services, helping Merck realize process efficiencies as well as significant savings.

Sigma-Aldrich is honored to receive the Sector Operational Award in recognition of our quality services and products, said Gilles Cottier, president of research essentials and Sigma-Aldrich's Executive Sponsor for Merck. As a global life science and high technology leader, we are committed to excellent customer service and quality while continually striving to meet or exceed the highest standards in the industry.

Jai Nagarkatti, CEO of Sigma-Aldrich, added, As a Merck supplier for laboratory chemicals and solvents, Sigma-Aldrich is pleased to continue to strengthen our partnership, providing excellent service to accelerate our customer's success.

In early 2006, Sigma-Aldrich was selected to provide a comprehensive suite of organic raw materials and sourcing services through its fine chemicals business unit (SAFC) that met Merck's needs. To date, utilization of this service has increased by 50%. As a Merck preferred supplier, Sigma-Aldrich has also been utilized for critical pre-clinical and clinical drug deliveries as well as associated analytical testing services.

Sigma-Aldrich is a leading life science and high technology company. Its biochemical and organic chemical products and kits are used in the diagnosis of disease, scientific and genomic research, biotechnology, pharmaceutical development, and as key components in pharmaceutical and other high technology manufacturing. The company has customers in life science companies, university, and government institutions, hospitals, and in industry. Sigma-Aldrich is committed to accelerating customer success through leadership in life science, high technology and service.


Related Links:
Sigma-Aldrich
Merck

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gynecological Examination Chair
arco-matic
Medical Monitor
SILENIO D
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.